Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 13.09
0.615 %
$ 1.72 B
Market Cap
87.27
P/E
DVAX - COST OF REVENUE
Cost of Revenue DVAX - Dynavax Technologies Corporation
50.2 M
LAST VALUE
-46.24%
2 YEAR CAGR
18.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR